Kezar Life Sciences, Inc. - Common Stock (KZR)

CUSIP: 49372L209

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock
Shares outstanding
7,437,095
Total 13F shares
4,328,239
Share change
+128,247
Total reported value
$21,120,201
Put/Call ratio
0%
Price per share
$4.88
Number of holders
40
Value change
+$284,256
Number of buys
12
Number of sells
19

Security key

49372L209

Report period

Q1 2025

Institutions

40

Top holders

10

Top shareholders of KZR - Kezar Life Sciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Equal Talent Investments Ltd
13D/G
Equal Talent Investments Limited
8.7%
616,502
$487,037 $0 28 Feb 2025
Avidity Partners Management LP
13F 13D/G
Company
6.9%
from 13D/G
502,600
$3,377,472 31 Dec 2024
TANG CAPITAL MANAGEMENT LLC
13F
Company
9.7%
720,000
$4,838,400 31 Dec 2024
13F
SUVRETTA CAPITAL MANAGEMENT, LLC
13F
Company
9.6%
716,759
$4,816,620 31 Dec 2024
13F
VANGUARD GROUP INC
13F
Company
3.7%
274,111
$1,842,026 31 Dec 2024
13F
ORBIMED ADVISORS LLC
13F
Company
2.6%
192,700
$1,294,944 31 Dec 2024
13F
ADAR1 Capital Management, LLC
13F
Company
2%
147,404
$990,555 31 Dec 2024
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
2%
145,666
$977,000 31 Dec 2024
13F
Affinity Asset Advisors, LLC
13F
Company
1.9%
142,316
$956,364 31 Dec 2024
13F
Peapod Lane Capital LLC
13F
Company
1.7%
123,994
$833,240 31 Dec 2024
13F
Stonepine Capital Management, LLC
13F
Company
1.5%
110,000
$739,200 31 Dec 2024
13F
SPHERA FUNDS MANAGEMENT LTD.
13F
Company
1.5%
108,473
$728,939 31 Dec 2024
13F
Ikarian Capital, LLC
13F
Company
1.4%
106,901
$718,375 31 Dec 2024
13F
TWO SIGMA ADVISERS, LP
13F
Company
1.3%
100,141
$672,948 31 Dec 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
1.2%
87,685
$589,243 31 Dec 2024
13F
Qiming U.S. Ventures Management, LLC
13F
Company
1.1%
82,871
$556,893 31 Dec 2024
13F
BlackRock, Inc.
13F
Company
1.1%
82,855
$556,785 31 Dec 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.9%
66,570
$447,464 31 Dec 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.83%
61,983
$416,526 31 Dec 2024
13F
Shay Capital LLC
13F
Company
0.8%
59,158
$397,542 31 Dec 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.7%
52,272
$351,268 31 Dec 2024
13F
BML Capital Management, LLC
13F
Company
0.65%
48,668
$327,049 31 Dec 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.58%
43,337
$291,225 31 Dec 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.43%
32,310
$217,123 31 Dec 2024
13F
RBF Capital, LLC
13F
Company
0.38%
28,253
$189,860 31 Dec 2024
13F
STATE STREET CORP
13F
Company
0.28%
21,093
$141,745 31 Dec 2024
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.28%
20,900
$140,448 31 Dec 2024
13F
MORGAN STANLEY
13F
Company
0.28%
20,609
$138,493 31 Dec 2024
13F
Marquette Asset Management, LLC
13F
Company
0.24%
17,805
$119,650 31 Dec 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.23%
16,870
$113,366 31 Dec 2024
13F
UBS Group AG
13F
Company
0.2%
14,840
$99,725 31 Dec 2024
13F
NORTHERN TRUST CORP
13F
Company
0.19%
13,940
$93,677 31 Dec 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.16%
11,884
$79,861 31 Dec 2024
13F
FMR LLC
13F
Company
0.11%
8,401
$56,455 31 Dec 2024
13F
Amundi
13F
Individual
0.11%
8,224
$54,114 31 Dec 2024
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.08%
6,177
$41,509 31 Dec 2024
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
1,036
$6,962 31 Dec 2024
13F
Global Retirement Partners, LLC
13F
Company
0.01%
1,000
$6,720 31 Dec 2024
13F
OSAIC HOLDINGS, INC.
13F
Company
0.01%
469
$3,151 31 Dec 2024
13F
SIMPLEX TRADING, LLC
13F
Company
0.01%
400
$2,000 31 Dec 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
170
$1,143 31 Dec 2024
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
109
$732 31 Dec 2024
13F
CITIGROUP INC
13F
Company
0%
51
$343 31 Dec 2024
13F
BARCLAYS PLC
13F
Company
0%
1
$7 31 Dec 2024
13F
Morningside Venture Investments Ltd
3/4/5 13D/G
10%+ Owner · Morningside Venture Investments Limited
class O/S missing
1,947,993
$1,753,194 15 Aug 2023
Nicholas Michael Mordwinkin
3/4/5
Chief Business Officer
class O/S missing
275,000
07 Jan 2024
Noreen Henig
3/4/5
Chief Medical Officer
class O/S missing
220,000
24 Jul 2023
Jason Dinges
3/4/5
Director
class O/S missing
26,000
28 Jun 2021
Jean-Pierre Sommadossi
3/4/5
Director
class O/S missing
26,000
28 Jun 2021

Institutional Holders of Kezar Life Sciences, Inc. - Common Stock (KZR) as of Q1 2025

As of 31 Mar 2025, Kezar Life Sciences, Inc. - Common Stock (KZR) was held by 40 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,328,239 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, Avidity Partners Management LP, BML Capital Management, LLC, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, ADAR1 Capital Management, LLC, ACADIAN ASSET MANAGEMENT LLC, Peapod Lane Capital LLC, and SPHERA FUNDS MANAGEMENT LTD.. This page lists 41 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders
42
Q1 2025 holders
40
Holder diff
-2
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 Value $ Q1 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .